Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,683 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003)

NCT05816252

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital (Chongqing Cancer Hospital) Chongqing, Chongqing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
View all 50 locations
View Trial Details
Active, Not Recruiting

A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer

NCT02779751

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Highlands Oncology Group - Duplicate 2 Springdale, Arkansas, United States
  • Univ of California San Francisco San Francisco, California, United States
  • University of Colorado School of Medicine Aurora, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI

NCT05601973

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Chu Angers Angers, France
  • Centre Hospitalier d'Avignon Avignon, France
  • Centre Léon Bérard Lyon, France
  • AO SM Misericorida Perugia Perugia, Italy
View all 18 locations
View Trial Details
Active, Not Recruiting

Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.

NCT03891953

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +33 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Novartis Investigative Site Dresden, Saxony, Germany
View Trial Details
Active, Not Recruiting

Induction Lorlatinib in Stage III Non-small Cell Lung Cancer

NCT05740943

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Peking Union Medical College Hospital Beijin, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Guangzhou Twelfth People's Hospital Guangzhou, Guangdong, China
  • The Second Xiangya Hospital of Central South University Changsha, Hunan, China
View Trial Details
Active, Not Recruiting

A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)

NCT02411448

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLA Hematology/Oncology - Santa Monica Los Angeles, California, United States
  • St. Charles Health System Denver, Colorado, United States
  • The Gastroenterology Group, P.C. Honolulu, Hawaii, United States
  • Cancer Center of Kansas Wichita, Kansas, United States
View all 106 locations
View Trial Details

Related conditions